Details of the Drug Formulaction

General Information of Drug Formulation (ID: F18052)

• Formulation Name: Propafenone 225 mg tablet
• Company: GlaxoSmithKline

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Propafenone	(DMPIBJK)	Tachyarrhythmias	BC71	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent